Anavex Life Sciences Balance Sheet Health
Financial Health criteria checks 5/6
Anavex Life Sciences has a total shareholder equity of $129.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $141.5M and $11.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$138.76m |
| Equity | US$129.78m |
| Total liabilities | US$11.75m |
| Total assets | US$141.54m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 12X1's short term assets ($141.5M) exceed its short term liabilities ($11.8M).
Long Term Liabilities: 12X1 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 12X1 is debt free.
Reducing Debt: 12X1 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 12X1 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 12X1 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.